“…Numerous research studies have highlighted the demanding situations faced by hemodialysis patients, consisting of immune disorders and impaired vaccine responses, warranting complete research into the hepatitis B vaccination fame (Raina et al, 2022). This observation, performed at Miangul Abdul Haq Jahanzeb Kidney Hospital in Swat, contributes to the developing body of information by delving into the immunization landscape among hemodialysis sufferers, with a particular cognizance on validating the effectiveness of the 20 microgram hepatitis B vaccine (Hussein et al, 2021;Mtingi-Nkonzombi et al, 2022). Understanding the vaccination status of these sufferers is critical for numerous reasons.…”